Table 1.
Demographic and Pathologic Characteristics of Patients who did and did not undergo 3-year Surveillance Imaging
Variable | Underwent 3 year scans | Did not undergo 3 year scans | Total | |||
---|---|---|---|---|---|---|
(n=52) | Followed at BIDMC (n=158) | (n=210) | ||||
No. | % | No. | % | No. | % | |
Sex | ||||||
Male | 32 | 62 | 91 | 58 | 123 | 59 |
Female | 20 | 38 | 67 | 42 | 87 | 41 |
Age, years | ||||||
Median | 54 | 54 | 54 | |||
Range | 16–76 | 24–86 | 16–86 | |||
Location | ||||||
Trunk | 15 | 29 | 65 | 41 | 80 | 38 |
Extremity | 16 | 31 | 48 | 30 | 64 | 30.5 |
Head/neck | 14 | 27 | 30 | 19 | 44 | 21 |
Unknown primary | 6 | 12 | 15 | 10 | 21 | 10 |
Prostate | 1 | 2 | 0 | 0 | 1 | 0.5 |
Breslow Thickness (mm) | ||||||
Median | 2.9 | 3.0 | 3.0 | |||
Range | 1.1–55 | 0.25–34 | 0.25–55 | |||
Ulceration | ||||||
Present | 11 | 21 | 58 | 37 | 69 | 33 |
Absent | 31 | 60 | 55 | 35 | 86 | 41 |
Unknown | 4 | 8 | 30 | 19 | 34 | 16 |
NA | 6 | 12 | 15 | 9 | 21 | 10 |
Clark level | ||||||
II | 0 | 0 | 2 | 1 | 2 | 1 |
III | 2 | 4 | 7 | 4 | 9 | 4 |
IV | 36 | 69 | 83 | 53 | 119 | 57 |
V | 6 | 12 | 22 | 14 | 28 | 13 |
Unknown | 2 | 4 | 20 | 13 | 22 | 11 |
NA | 6 | 12 | 24 | 15 | 30 | 14 |
Mitosis, mm2 | ||||||
Median | 3 | 6 | 4 | |||
Range | 0–60 | 0–33 | 0–60 | |||
Stage | ||||||
IIB | 6 | 12 | 27 | 17 | 33 | 16 |
IIC | 4 | 8 | 11 | 6 | 14 | 7 |
IIIA | 18 | 35 | 15 | 10 | 33 | 16 |
IIIB | 10 | 19 | 43 | 27 | 53 | 25 |
IIIC | 14 | 27 | 62 | 39 | 76 | 36 |
Interferon | ||||||
Yes | 45 | 87 | 100 | 63 | 145 | 69 |
No | 7 | 13 | 58 | 37 | 65 | 31 |